Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma.

Saved in:
Bibliographic Details
Title: Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma.
Authors: Lukoseviciute M; Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Theodosopoulou A; Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Holzhauser S; Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Dalianis T; Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Kostopoulou ON; Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.
Source: Oncology reports [Oncol Rep] 2023 Jun; Vol. 49 (6). Date of Electronic Publication: 2023 May 05.
Publication Type: Journal Article
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1791-2431
DOI:10.3892/or.2023.8562